Neoplasia/BPH

	TFPI2 expression predicts resistance to immunotherapy plus tyrosine kinase inhibitor and informs first-line therapy selection in metastatic renal cell carcinoma. Cell Oncol (Dordr) Wang J, Du L, Wang Y, Wang H, Zhu Y, Xu X. PMID: 42171882 [PubMed - as supplied by publisher]
	Renal function outcomes following endoscopic management of upper tract urothelial carcinoma. World J Urol Korn P, Essien M, Pallauf M, Cheaib J, Lokeshwar S, Herrera-Caceres JO, Small A, Raskolnikov D, Kleinmann N, Shvero A, Matin SF, Labbate C, Kaimakliotis H, Tachibana I, Linehan J, Choe J, Shah O, Movassaghi M, Huang W, Persily J, Perecman A, Canes D, Pessoa RR, Potretzke A, Raman JD, Singla N. PMID: 42171772 [PubMed - indexed for MEDLINE]
	Perirectal spacers and endorectal balloons in external beam radiotherapy for prostate cancer: aÂ review of prospective studies. Strahlenther Onkol Moll M, Mendenhall NP, Goldner G, Miszczyk M, Sushant S, Lütgendorf-Caucig C, Hug E, Mendenhall WM. PMID: 42171762 [PubMed - as supplied by publisher]
	First-Line Systemic Treatments for Metastatic Hormone-Sensitive Prostate Cancer: Updated Systematic Review and Network Meta-analysis. J Urol Miyajima K, Miszczyk M, Matsukawa A, Roessler N, Inoue S, Urabe F, Mori K, Yanagisawa T, Karakiewicz PI, Agarwal N, Briganti A, Kimura T, Shariat SF. PMID: 42171515 [PubMed - as supplied by publisher]
	Interplay of the 3D genome and epigenome in androgen-driven prostate cancer. Epigenomics Campbell EM, Challis D, Clark SJ, Achinger-Kawecka J. PMID: 42170760 [PubMed - as supplied by publisher]
	Effects of neoadjuvant novel endocrine therapy combined with prostatic artery embolization on SII, PNI, and bRFS in patients with prostate cancer. Am J Transl Res Zhao B, Li B, Jiang J, Ma Q, Zhang H, You J, Li K. PMID: 42170485 [PubMed]
	A case report of rectal squamous cell carcinoma following radiation therapy for prostate cancer: a management dilemma. J Gastrointest Oncol Nwokeocha SO, Kumar J, Soni R, Shah S, Patel AV. PMID: 42169951 [PubMed]
	A cohort study investigating differences in skeletal muscle mitochondrial function between prostate cancer patients and healthy controls. BMC Cancer Smart TF, Bass JJ, Crossland H, Cox J, Atherton PJ, Lund JN, Phillips BE. PMID: 42168935 [PubMed - as supplied by publisher]
	Robotics Is Not Important Because It Is Robotic: Re: Jeremy Y. Teoh, Francesco M. Bracco, Julius H. Wong, et al. A Novel Transurethral Robotic Platform for Performing En Bloc Resection of Bladder Tumour: Results from the First Phase of the VIABLE Trial. Eur Urol Oncol 2026;86:111-15. Eur Urol Oncol Güven S, Soyturk S, Herrmann T. PMID: 42168051 [PubMed - as supplied by publisher]
	Reply to Daoyuan Li's Words of Wisdom re: Bacillus Calmette-GuÃ©rin Plus Mitomycin Versus Bacillus Calmette-GuÃ©rin Alone for Bacillus Calmette GuÃ©rin-naÃ¯ve Non-Muscle-Invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.011. Eur Urol Hayne D, Zhang AY, Thomas H, Redfern AD, Davis ID, Stockler MR. PMID: 42168001 [PubMed - as supplied by publisher]
	Impact of intraoperative intravenous heparin bolus on clinical outcomes during radical nephrectomy and IVC tumor thrombectomy in renal cell carcinoma with level I-IV IVC thrombus: A multi-institutional study. Urol Oncol Aydin AM, Dehghanmanshadi A, Mukhtar V, Siegel ER, Moon S, Biben E, Patel K, Kuykendall K, Fang AM, Langford T, Gokden N, Chang D, Kwon D, Ferguson JE, Peyton CC. PMID: 42167989 [PubMed - as supplied by publisher]
	Is Perirenal Fat an Active Player in Renal Cell Carcinoma Tumorigenesis? A Radiologic-Pathologic Correlation Study. Fr J Urol Gökkurt Y, Karakan T, Kesero, Bayburtluo, Demir DÖ, Y, Kaçan T. PMID: 42167716 [PubMed - as supplied by publisher]
	A DNA Methylation-based algorithm Improves Lung Cancer risk prediction in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Lung Cancer Dawes K, Mills JA, Hoffman RM, Froehlich EM, deBlois K, Sieren JC, Williams C, Merkle S, Long JD, Beach SR, Philibert RA. PMID: 42167026 [PubMed - as supplied by publisher]
	Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer. J Clin Oncol Murthy V, Maitre P, Pal M, Arora A, Phurailatpam R, Sharma R, Gudipudi D, Rajappa S, Pujari L, Bandekar B, Joseph D, Kannan S, Krishnatry R, Misra A, Joshi A, Noronha V, Prabhash K, Menon S, Bakshi G, Prakash G. PMID: 42166701 [PubMed - as supplied by publisher]
	Disparities in prostate cancer screening practices among general practitioners and urologists (PROSHADE study): A cross-sectional study. PLoS One Lumbreras B, Parker LA, Alonso-Coello P, Caballero-Romeu JP, Párraga-Martínez I, Prieto L, Moral-Peláez I, Del Campo-Giménez M, Gómez-Pérez L, Cebrián A, López-Garrigós M, Ronda E, Guilabert M, Canelo-Aybar C, Hernández-Aguado I. PMID: 42166422 [PubMed - indexed for MEDLINE]
	Tubulocystic Renal Cell Carcinoma: A Scoping Review of Radiological, Clinicopathological, and Immunohistochemical Features. Urol Int AbuHaweeleh MN, Alhyari A, Abuhayeh N, Emam F, Al-Qudimat AR, Al Rumaihi K, Khalil IA. PMID: 42166387 [PubMed - as supplied by publisher]
	Axitinib-Pembrolizumab and Adverse Event Management in Patients With Advanced Renal Cell Carcinoma. JAMA Netw Open Shah NJ, Ababio Y, Eccleston A, Rao D, Kelly SP, Chang J, Lucht S, Paydar C, Van Doren BA, Bland E, John W, Giegerich S, Laney J, Feinberg B, Zarrabi KK. PMID: 42166160 [PubMed - indexed for MEDLINE]
	Effectiveness of contemporary treatments for iatrogenic urethral strictures following endoscopic management of benign prostatic hyperplasia: a comprehensive review. World J Urol Lo Re M, Cadenar A, Pezzoli M, Fuligni E, Abbasi B, Bia, Chierigo F, Frankiewicz M, Karapanos L, Klemm J, Mantica G, Neuville P, Bucca B, Oszczud, Redmond E, Scherñuk J, Tinajero JD, Verla W, Minervini A, Vetterlein MW, Cocci A, Trauma and Reconstructive Urology Working Party of the European Association of Urology Young Academic Urologists. PMID: 42165905 [PubMed - indexed for MEDLINE]
	Androgen Receptor Expression in Urothelial Bladder Cancer-A Systematic Review and Meta-Analysis. ANZ J Surg Buckby A, Gholami M, Hong M, O'Callaghan M. PMID: 42165524 [PubMed - as supplied by publisher]
	Treatment and progression of patients in Sweden with metastatic castration-sensitive prostate cancer. Acta Oncol Styrke J, Jellvert Å, Hjälm Eriksson M, Sandin F, Axén E, Jabbar S, Juhl Norgaard K. PMID: 42165189 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 188044

Page 1 of 9403



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy